Cited by 110Alzheimer's disease research and treatmentsNeuroinflammation and Neurodegeneration MechanismsDementia and Cognitive Impairment Research

Diffuse plaques associated with astroglial amyloid β protein, possibly showing a disappearing stage of senile plaques

Yamaguchi, H., Sugihara, Shiro, Ogawa, Akira, Saido, Takaomi C., Ihara, Yasuo·1998·Acta Neuropathologica

Abstract

To clarify whether senile plaques disappear, we examined amyloid beta protein (A beta) deposits in non-demented subjects, and found novel diffuse plaques associated with astroglial A beta. Formalin-fixed paraffin-embedded sections from cortical areas were immunolabeled with a panel of A beta antibodies, and astroglial and microglial markers. Cerebral A beta deposition was primarily found as diffuse plaques (DP) in these subjects. A subset of DP was associated with clusters of intensely A beta-positive small granules. The clusters, which were located just adjacent to astroglial nucleus, had the characteristics of lipofuscin granules and, therefore, were quite different from "small stellate deposits". Substantial amounts of A beta-positive granules were found inside astrocytes by dual labeling of A beta and glial fibrillary acid protein, and the majority of astroglial A beta immunoreactivity was located on lipofuscin granules. A beta-positive granules lacked immunoreactivity with antisera for the N-terminal region of A beta. These peculiar DP showed a much weaker staining than ordinary DP. The DP associated with astroglial A beta were found in about one third of the subjects, although the density varied widely among individuals. From these findings, we propose that DP, which are associated with the N-terminal truncated A beta in astrocytes, represent the disappearing stage of senile plaques.

Integrity signals

Registry

Crossref · 10.1007/s004010050790

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

No citation lists for this paper

No citation lists for this paper yet — checked again daily.

References 18 · Cited by 110

Authors
Yamaguchi, H., Sugihara, S., Ogawa, A., Saido, T. C., & Ihara, Y.
Affiliations
  • Gunma University (JP)
  • Gunma Prefectural Cancer Center (JP)
  • Tokyo Metropolitan Institute of Medical Science (JP)
  • The University of Tokyo (JP)
Venue
Acta Neuropathologica
Published
1998-03-23
Volume
95
Issue
3
Pages
217-222
ISSN
  • 0001-6322 (ISSN-L)
  • 1432-0533
OpenAlex
W2035394884
Cited by
110
References
18
Citations by year
2026: 2 · 2025: 3 · 2024: 2 · 2023: 3 · 2022: 3 · 2021: 3 · 2020: 3 · 2019: 2 · 2018: 2 · 2017: 2 · 2016: 4 · 2015: 2 · 2014: 6 · 2013: 3 · 2012: 5
FWCI
4.09
Type
journal article
Language
en
Open access
closed
Locations
  • Acta Neuropathologica (publishedVersion)
  • PubMed (publishedVersion)
Funders
Life Sciences Research Foundation
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Keywords
amyloid-beta, diffuse plaques, amyloid plaques, lipofuscin granules, astrocytes, microglia, glial fibrillary acidic protein, Alzheimer's disease, cortical amyloid deposition
MeSH terms
Aged, Aged, 80 and over, Alzheimer Disease, Antibody Specificity, Astrocytes, Humans, Middle Aged, Biomarkers, Amyloid beta-Peptides, Plaque, Amyloid

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review